EFPIA - NEWSLETTER

Trouble reading this email? View it in your browser


		EFPIA Newsletter 14 April 2022

New proposals from the research-based pharmaceutical industry should reduce inequalities in patient access to medicines across Europe

Back Innovation, Boost Access

The new pledge from EFPIA member companies should drastically increase the availability of innovative medicines in EU countries and decrease the time patients must wait for new medicines by several months.

EFPIA member companies commit to file for pricing and reimbursement in all EU countries as soon as possible and no later than 2 years from the central EU market authorisation, provided that local systems allow it. The commitment is designed to help deliver faster, more equitable access to medicines for patients across Europe.

Read more

Blogs

DIA Leader of Tomorrow 2022 – bringing students and young professionals closer to the innovative...
13 April 2022 - Andreea Iordache

Leader of Tomorrow is a community created by DIA that is tailor-made for students and young professionals in life sciences... Read more

Events

Future Clinical Trials conference – from tomorrow to 2030 – Why choose the Nordics?
07 June 2022 (in Helsinki or virtually)

The event will take place in Team Finland House (Porkkalankatu 1, Helsinki). It is also possible to follow the event... Read more

11th European Conference on Rare Diseases & Orphan Products
27 June 2022 (Virtual event)

Putting rare diseases policy into action. Read more

We published

Shortening the WAIT - Patient Access to Medicines in Europe
06 April 2022 (News & Events)

Disparities in the time it takes for patients to access new medicines in different EU Member States are increasing. Read more

Are medicines affordable for health systems? The myths, the facts and the way forward
07 April 2022 (News & Events)

Pharmaceutical expenditure has been stable as a share of total healthcare expenditure in all European countries included... Read more

What we are reading

Pharma industry insists European drugs are affordable
On 07 April 2022 (thepharmaletter)

An interview with Thomas Allvin, EFPIA Executive Director, Strategy and Healthcare Systems Read more

New EU Portal To Track Pricing & Reimbursement Applications
On 11 April 2022 (Pink Sheet)

Move Will Help Uncover Root Causes Of Medicines Unavailability & Patient Access Delays. Read more

UK launches its ‘Netflix-style’ payment model for antibiotics
On 12 April 2022 (pharmaphorum)

The UK is poised to become the first country in the world to launch a new payment model for antibiotics that could reverse... Read more

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
E-mail:Communications@efpia.eu